Ian Wijaya is a Managing Director in Lazard’s Global Healthcare Group in New York. An investment banker for 17 years, he joined Lazard in 2011 and co-founded the Firm’s healthcare services practice. Mr. Wijaya focuses on M&A and strategic advisory for healthcare services and biopharma companies.
Mr. Wijaya has experience in a wide range of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, financial restructurings and reorganizations, joint ventures, and other matters and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history (sale of Aetna to CVS for $77bn, sale of Express Scripts to Cigna for $67bn, and Roche’s $49bn squeeze-out of Genentech).
He regularly advises senior executives and Boards of Directors of healthcare companies regarding the strategic and financial implications of a broad range of trends and dynamics facing payers, providers, biopharma and others, including with regard to ways to innovate and disrupt the landscape, as companies seek new ways to improve quality of outcomes and reduce costs to the system.
Prior to joining Lazard, Mr. Wijaya was an investment banker at Greenhill & Co., in New York, where he focused on healthcare M&A, but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman, Sachs & Co. and the financial restructuring group of Houlihan Lokey.
Mr. Wijaya has an M.B.A. in Finance and Strategy from Northwestern University’s Kellogg School of Management, and a B.A. (cum laude) from Dartmouth College, where he focused his studies on the history of African-American civil rights.
Mr. Wijaya is an avid musician, composing original songs in his home studio, on the guitar, bass, piano and drums.